glp-1 iih Exenatide (a receptor agonist) rapidly lowered intracranial pressure in active IIH, with a sustained signal at 12 weeks and no meaningful weight change. The authors suggest an ICP-lowering GLP-1 Agonists May Help Reduce

Onsera CEO Jeff Bernhard explains perfectly why the future of obesity care is about more than just access Ready to rethink your GLP-1 strategy

Cell mutation this field has had the maximum amount of studies

Packed with potent antioxidants, these innovative formulations are designed to nourish and protect your skin from within

In sum, Antioxidants have the potential to prevent chemotherapy-induced peroxidation, decrease oxidative stress, and protect normal tissue

As high intracellular iron worsens HIV-1 prognosis and iron proteins are upregulated in HAND, ferroptosis-induced neurodegeneration (FIN) may contribute to this disorder (Patton et al., 2017